ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$ARGX:NASDAQ · ARGENX SE

Sector: health

Conviction from: NASDAQ

52-week range: 661.851,073

argenx is a biotechnology company that develops antibody-based therapies for severe autoimmune diseases, including its FcRn-blocker Vyvgart.

4 tracked filer(s) hold this · 1 opened, 3 added, 0 trimmed in 30-SEP-2026

Aggregate 13FScore 58 — mean of 4 scored holder(s) · buyers (new/add) avg 58. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy9,300$8,917,8630.0%
Steve Cohen / Point7275Added +126%103,544$99,289,3770.1%
Bridgewater55Added +1016%21,842$20,944,5120.1%
Ancora42Added +233%20$19,1780.0%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

4 disclosed trade(s) by 2 filer(s).

Trade dateWhoTypeAmount
2026-10-27Gilbert Cisneros CA31BUY$1,001 - $15,000PTR
2026-10-15Gilbert Cisneros CA31BUY$1,001 - $15,000PTR
2026-10-14Gilbert Cisneros CA31BUY$15,001 - $50,000PTR
2026-03-30Alan Armstrong senateBUY$1,001 - $15,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.